Panelists discuss how the evolution of anal cancer treatment began with the 1974 Nigro regimen combining 5-fluorouracil and ...

Pembrolizumab combined with chemoradiation shows promising long-term efficacy and safety in treating advanced non-small cell ...

In an open label, phase 2 trial, 30 patients with MIBC received chemoradiation (mitomycin C plus capecitabine and 20×2.75 Gy to the bladder) combined with four 3-weekly cycles of nivolumab 3 mg ...

Locally advanced non–small cell lung cancer (NSCLC) constitutes a third of new NSCLC diagnoses worldwide. 1, 2 For patients with unresectable disease, the historical standard treatment was definitive ...

Conclusions: Chemoradiation combined with immunotherapy as an adjuvant therapy demonstrated superior survival outcomes over observation in resectable ECC/GBC patients with a well-tolerable safety ...

Adding immunotherapy to chemoradiation therapy (CRT) for limited-stage small cell lung cancer (SCLC) failed to improve survival in a randomized trial. As compared with CRT alone, concurrent ...

“Deintensification of chemoradiation treatments for HPV-associated oropharyngeal cancers is of very high interest to patients and researchers, but our study makes clear that these approaches ...

In this study, Dr. Yom and her team tested two lower-intensity treatment regimens against a control arm of more standard chemoradiation for people with HPV-associated, locoregionally advanced ...

Since 2001, postoperative chemoradiation has been the standard of care for gastric cancer, particularly in North America, based on findings from that year's INT0116 trial.

Of note, when an outcome is not reached in a clinical trial, it means that half of the patients in the trial are alive when this was assessed by researchers. “The AFT-16 trial is the first to our ...

Dr Prathamesh Pai, director and H&N surgeon, Punyashlok Ahilyadevi Holkar Head & Neck Cancer Institute of India, said, “Our study confirms that the relative mortality has gone down from 50% to ...